CSBR Stock Reaches Annual Peak of $9.94 Due to Growth

Champions Oncology: Feeling Met Like the Big Apple Champions Oncology, Inc. (NASDAQ: CSBR) has really stepped into the spotlight recently, hitting a fresh 52-week high at $9.94. With a market cap in the ballpark of $133 million and annual revenue of around $54 million, this biotech wonder is trading above its InvestingPro Fair Value. Tech […]